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Abstract
There is some evidence that the endothelium dependent vasodilatation of coronary arteries is impaired in both types of
diabetes. The underlying mechanisms are not yet clear, in particular whether this defect is caused by a direct effect of diabetes
on the activity and the expression of nitric oxide synthases (NOS) or indirectly by an enhanced inactivation of nitric oxide.
Methods: To study this question we determined the activity (conversion of L-arginine to citrulline) and the mRNAs encoding
the isoforms of NOS (using polymerase chain reaction after reverse transcription of the mRNAs into cDNAs by reverse
transcriptase) in hearts of streptozotocin diabetic rats and in rat heart endothelial cells (RHEC). The formation of reactive
oxygen intermediates (ROI) was measured by the dichloro-dihydro-fluorescein method. Results: The activity of total NOS
and the amounts of mRNAs encoding ecNOS and iNOS were dependent on the duration of diabetes. After a diabetes
duration of 4 to 6 weeks both the total activity as well as the mRNAs encoding ecNOS and iNOS were elevated. A reduction
of NOS activity and the amounts of mRNAs of ecNOS and iNOS was only seen after a diabetes duration longer than
20 weeks, a time at which a loss of endothelium has been described. In RHEC, high glucose (22 mM) and H2O2 (100 WM)
were able to increase the mRNA encoding ecNOS, but not iNOS. This increase in ecNOS mRNA was inhibited by lipoic acid
(1 WM). In addition, high glucose (22 and 30 mM) led to an enhanced formation of ROI and to activation of the transcription
NFUB. Conclusion: These observations suggest that diabetes causes a temporary increase in NOS activity and ecNOS
mRNA in the rat heart which is presumably the consequence of an enhanced oxidative stress exerted by hyperglycaemia.
Together with previously published observations, our data suggest that the impairment of endothelium dependent
vasodilatation in rat heart is not the consequence of a reduced activity and expression of NOS, but is caused by an enhanced
inactivation of nitric oxide by ROI. ß 2000 Elsevier Science B.V. All rights reserved.
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1. Introduction
Recently we have shown in the isolated perfused
rat heart that diabetes mellitus is associated with an
impairment of endothelium dependent relaxation of
coronary vessels [1,2]. The endothelium dependent
increase in coronary £ow was signi¢cantly impaired
depending on the duration and severity of diabetes.
On the other hand, the response to sodium nitro-
prusside as well as the maximal coronary £ow were
not altered indicating a speci¢c impairment of endo-
thelium dependent dilatations and excluding changes
in the response of smooth muscle cells. This defect
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was speci¢cally related to the generation and action
of NO, since the formation and release of prosta-
glandins were excluded under the experimental con-
ditions used [1,2]. Similar evidence for an impairment
of endothelium dependent vasodilatation has also
been shown in coronaries of diabetic patients [3]
and for various other types of vessels [4^8].
The cellular mechanisms involved in the develop-
ment of endothelial dysfunction in diabetes remain to
be elucidated. There is some evidence that in the
heart the impaired endothelium dependent vasodila-
tation can be restored by superoxide dismutase or
pre-treatment of the diabetic rats with high doses
of K-tocopherol [1] suggesting that reactive oxygen
radicals may play a role. This assumption is sup-
ported by very recent clinical studies showing that
the impaired endothelium dependent vasodilatation
can be improved in diabetic patients by treatment
with antioxidants [9,10]. On the other hand, diabetes
might also directly alter the activity and expression
of nitric oxide synthases (NOS) and thereby lead to a
diminution in the release of nitric oxide. The under-
standing of the mechanisms underlying the impair-
ment of endothelium dependent vasodilatation is
hampered by the fact that no data are available
whether and in which way diabetes in£uences the
activity and expression of NOS in the heart. Three
isoforms of NOS have been described in the heart
[11,12]: a constitutive form occurring mainly in the
nerve tissue (nNOS or NOS I), the inducible form
(iNOS or NOS II) and the endothelial form which is
constitutively expressed, but dependent on intracellu-
lar calcium (ecNOS or NOS III). To gain insight into
these questions we studied the in£uence of diabetes
on the expression of the NOS isoforms in heart tis-
sue, and tested whether the expression of NOS is
a¡ected by high glucose.
2. Materials and methods
2.1. Animals
Experiments were performed with hearts and cells
isolated from male Wistar rats (Wistar-Unilever,
Harlan-Winkelmann, Borken, Germany). The ani-
mals were housed under standard conditions in the
animal laboratory of the Diabetes Research Institute.
Diabetes of 8 week old rats was induced by intra-
peritoneal application of streptozotocin (60 mg/kg
body weight) as previously described [1,2,13]. The
onset of diabetes was proven 1 week after injection
of streptozotocin by determination of blood glucose
(glucose oxidase method), glucosuria (Haemo-Glu-
kotest, Boehringer-Mannheim, Germany) and glycat-
ed haemoglobin (Isolab, Munich, Germany). Only
animals with a blood glucose higher than 15 mM
and a HbA1 higher than 12% were taken as diabetic
rats.
2.2. Supplementation with K-tocopherol
All animals had free access to water. Control ani-
mals received standard laboratory chow for rats
(Sni¡, Soest, Germany) containing 163 mg tocopher-
ol equivalents/kg diet, leading to a serum vitamin E
level of 8.2 þ 0.4 mg/dl, measured by high perform-
ance liquid chromatography [14]. To obtain a high K-
tocopherol diet, the control diet was supplemented
with tocopherol acetate (RRR-K-tocopherol-acetate;
Corvitol, Henkel AG, Du«sseldorf, Germany) to in-
crease the amount of K-tocopherol to 1.3 g tocopher-
ol acetate/kg corresponding to 610 mg tocopherol/kg
diet. The serum K-tocopherol values of supplemented
animals rose up to 18.9 þ 0.6 mg/dl.
2.3. Preparation of tissues
Animals were anaesthetised by ether. After thora-
cotomy the hearts were perfused with phosphate
bu¡ered saline (PBS), the atria were cut o¡, the ven-
tricles shock-frozen in liquid nitrogen and stored at
380‡C. For analysis, frozen hearts were pulverised
under liquid nitrogen, the powder was used for NOS
activity measurements as well as for expression anal-
ysis.
2.4. Preparation and cultivation of rat heart
endothelial cells (RHEC)
RHEC were isolated from the collagenase perfused
heart as described by Linssen et al. [15]. Cells were
cultivated (37‡C, 95% humidity, 8% CO2) in Dulbec-
co’s modi¢ed Eagle’s medium (Sigma-Aldrich, Dei-
senhofen, Germany) to which 0.06 mM KH2PO4,
0.11 mM KCl, 5.5 mM NaCl, 0.34 mM NaHPO4,
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0.03 mM HEPES, 4 mM L-2-aminoglutaminic acid,
1.6U105 U/l penicillin, and 68.6 mM streptomycin
(all ¢nal concentrations) had been added. The me-
dium contained 18.5% (v/v) foetal calf serum (Sigma)
and additionally 0.003% (w/v) endothelial cell growth
supplement (Sigma) up to the ¢fth passage.
The endothelial cells were identi¢ed by the uptake
of acetylated low density lipoproteins as described by
Voyta et al. [16] and by positive staining for factor
VIII [17,18]. Because of the low yield, only endothe-
lial cells from passages higher than 10 could be used
for the experiments.
2.5. Preparation of cardiomyocytes
Cardiomyocytes were isolated from the collagenase
perfused heart as described by Fischer et al. [19].
Large fragments of connected cells were excluded
by ¢ltering the solution (pore diameter 200 Wm).
Traces of endothelial cells were removed as super-
natant by centrifugation (10Ug, 2 min, RT). The
cardiomyocytes in the pellet were gently suspended
and applied onto the top of an albumin solution (15
mM buthanedione-monoxime, 1 mM CaCl2, bovine
serum albumin (BSA) fatty acid-free 1%(w/v) for sed-
imentation (3 min, RT). The sedimented cardiomyo-
cytes were resuspended in disruption bu¡er and the
cell pellet (200Ug, 5 min, RT) was either shock-fro-
zen for analysis of activity or resuspended in Trizol
for isolation of RNA.
2.6. Determination of total NOS activity
Total NOS activity was determined as described
by Bredt and Snyder [20]. Eighteen mg tissue powder
was pottered in 150 Wl disruption bu¡er (4‡C: 50
mM Tris bu¡er pH 7.4; 1 mM EDTA; 5 mM mer-
captoethanol; protease inhibitors: 10 Wg/ml pepstatin
A, 10 Wg/ml leupeptin and 90 Wg/ml phenylmethyl-
sulfonyl £uoride). After ¢ve cycles of freeze^thawing
and additional mechanical disruption by pipetting,
50 Wl aliquots were used for measurement of NOS
activity. To each aliquot, 50 Wl of reaction mix was
added containing (¢nal concentrations): 50 mM Tris
bu¡er pH 7.4; 2 WM L-arginine; 2 WCi/ml 3H-L-argi-
nine (Amersham, Brunswick, Germany); 2 mM
NADPH; 10 WM FAD/FMN; 0.5 mM EDTA and
0.5 mM CaCl2. The reaction was incubated at 37‡C
for 45 min. Thereafter the reaction was stopped by
the addition of 500 Wl 40 mM HEPES bu¡er (pH 5)
containing 2 mM EDTA/EGTA. The 3H-L-citrulline
formed was separated from 3H-arginine by the cat-
ion-exchanger Dowex-50 WX8 (Serva, Heidelberg,
Germany) in 1 ml glass columns rinsed with 5 ml
HEPES bu¡er. The eluted samples were quanti¢ed
by liquid scintillation counting (Beckmann, Munich,
Germany). The NOS activity was calculated as
formed citrulline: fmol/min/mg heart protein.
2.7. Western blot
NOS protein was determined by immuno-chemical
staining using speci¢c antibodies directed against the
various NOS isoforms. Brie£y, aliquots of the pulv-
erised tissue were homogenised in 10 ml ice-cold
bu¡er (Ultraturrax, Janke and Kunkel, Staufen, Ger-
many) and a glass homogeniser. The bu¡er for ho-
mogenisation contained: 25 mM HEPES pH 7.4,
4 mM EDTA, 250 mM saccharose, peptidase/pro-
tease inhibitors: 25 mM benzamidine, 0.2 mM
PMSF, 1 WM leupeptin, 1 WM pepstatin, 1 U/l apro-
tinin. By di¡erential centrifugation (11 000Ug,
10 min, 4‡C) the plasma membrane fraction was
sedimented. The pellets were resuspended in TES
bu¡er containing: 10 mM Tris, 0.1 mM EDTA, 2%
sodium dodecyl sulfate (SDS), pH 7.5. Protein con-
centration was determined by the BCA protein assay
(Pierce/KMF, St. Augustin, Germany).
Aliquots (40 Wg protein) in 30 Wl loading bu¡er
(62.5 mM Tris, glycerol 10% (w/v), bromophenol
blue (0.01% w/v)) and the molecular weight stan-
dards (Sigma) were treated by heat (95‡C, for
6 min). The denatured proteins were separated by
SDS^polyacrylamide gel electrophoresis (7.5% gel).
After blotting the proteins onto nitrocellulose mem-
branes, the membranes were washed (500 mM Tris
pH 7.5, 200 mM NaCl) and treated with blocking
bu¡er (40 min, 500 mM Tris, 200 mM NaCl,
0.05% Tween 20, 3% BSA, 10% milk powder, pH
7.5). Thereafter the membranes were incubated with
ecNOS antibody (8 h, 4‡C, Transduction Laborato-
ries/Dianova, Hamburg, Germany, diluted 1:2500 in
PBS containing 10% milk powder, pH 7.5), washed
¢ve times for 2^3 min at RT with washing bu¡er
(containing 0.3% Tween) and once with washing
bu¡er without Tween (500 mM Tris, 200 mM
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NaCl, pH 7.5) for 20 min. Membranes were blocked
as described and incubated with the peroxidase-con-
jugated anti-mouse-antibody (1:2000 in PBS, 10%
milk powder, pH 7.5) for 1 h. After washing with
the Tween-containing bu¡er the membranes were
treated with the enhanced chemiluminescence
(ECL) solution as described by the manufacturer
(ECL kit, Amersham-Buchler, Brunswick, Ger-
many). The quanti¢cation of the signals was per-
formed by a densitometer (Scanner XRS, Omni-Me-
dia, Cambridge, MA, USA, connected to a Whole-
Band analyser from Millipore, Eschborn, Germany).
Immuno-detection of nNOS and iNOS was per-
formed in the same way using commercially available
antibodies (nNOS, Biomol, Hamburg, Germany, di-
lution 1:1000; iNOS, Calbiochem, Bad Soden, Ger-
many, dilution 1:1000). In some experiments, radio-
labelled protein A (125I-protein A, Amersham-
Buchler) was used to detect the bound NOS antibod-
ies instead of the ECL system.
2.8. Determination of NOS expression
One hundred mg tissue powder was pottered in
100 Wl Trizol (Gibco Life-Technologies, Eggenstein,
Germany). Total RNA was isolated according to the
manufacturer’s protocol. The RNA was quanti¢ed
photometrically and its quality was analysed by
formamide-gel electrophoresis both according to the
procedure described by Sambrook et al. [21]. cDNA
synthesis of 2 Wg total RNA was started by 2 Wg
oligo dT16 primer (Pharmacia, Uppsala, Sweden).
After heating the RNA and primer in 10 Wl of H2O
(60‡C, 5 min), 30 Wl of reaction solution was added
to perform ¢rst strand cDNA synthesis using Super-
script (components and incubation times according
to the manufacturer’s protocol, Gibco Life-Technol-
ogies, Eggenstein, Germany). The resulting cDNA
was analysed for the steady state content of the iso-
forms of NOS as well as the amount of GAPDH
mRNA as house-keeping gene. All polymerase chain
reactions (PCR) were performed using 0.15 Wg
cDNA and 0.5 WM of each primer for a ¢nal 20 Wl
volume per PCR. The ampli¢cations were processed
under oil and terminated by a ¢nal elongation at
72‡C for 10 min. PCR conditions have been opti-
mised for each product individually. The product
amount was analysed in the exponential phase of
the PCR which was determined as part of the opti-
mising process. This method allows the comparison
of initial mRNA amounts of one individual mRNA
in di¡erent samples being processed in parallel [22].
cNOS primer sequences were chosen based on the
sequence U02534ACÿEMBL using PCGene (Intelli-Ge-
netics, Mountain View, USA) sense: 5PCAG AGC
ATA CCC GCA CTT C 3P, antisense: 5PCCA
GAC GCA CCA GGA TTG T 3P ; PCR was carried
out using 1 mM MgCl2, and 0.5 U Taq (Gibco Life
Technologies, Eggenstein, Germany)). The reaction
was performed for 32 cycles (92‡C at 30 s; 56‡C
for 60s; 72‡C for 60 s). iNOS primer sequences are
according to Susheck et al. [23] based on the se-
quence D14051ACÿEMBL : PCR was carried out using
1.5 mM MgCl2 and 0.5 U Taq-polymerase (Amer-
sham). The reaction was performed for 32 cycles
(92‡C for 30 s; 62‡C for 60 s; 72‡C for 60 s).
nNOS primer sequences are based on the sequence
U31466ACÿEMBL : sense: 5P TTC GAA TAC CAG
CCT GAT CCC TGG AA 3P, antisense: 5PCCC
AGT TCT TCC AGG AGG GTG TCC AGA
GCA TG 3P. The PCR was carried out using 3 mM
MgCl2 and 0.5 U Taq-polymerase (Gibco Life
Technologies) using a PCR setting of (92‡C for
30 s; 62‡C for 60 s; 72‡C for 60 s) for 32 cycles.
The GAPDH primer was chosen according to Liu
et al. [24]. The PCR was performed using 1.5 mM
MgCl2 and 0.5 U Taq-polymerase (Gibco Life Tech-
nologies) according to the following protocol: 92‡C
for 30 s; 57‡C for 60 s; 72‡C for 180 s) for 30 cycles.
The identity of all PCR products has been proven
by multiple direct sequencing. To compare the
amount of steady state mRNA of each analysed
product, 5 Wl of each PCR were analysed in a 2%
(v/w) agarose gel containing: 0.5 Wg ethidium bro-
mide/ml in 0.04 mM Tris-acetate and 1 mM
EDTA. The PCR signals were photographed and
quanti¢ed (Bioimage Whole-Band-Analyser, Milli-
pore-BI-Systems, Eschborn, Germany) All NOS
PCR signals were normalised on the GAPDH signal
of the identical cDNA. For one RNA sample, three
cDNAs were prepared in parallel, each cDNA was
used to analyse all expression signals. For the ¢nal
values the normalised PCR product amounts result-
ing from parallel RNAs representing one group of
animals or cells were combined to calculate the mean
and the standard deviation.
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2.9. Determination superoxide anions
To analyse the generation of reactive oxygen inter-
mediates (ROI), RHECs were stained with 2P,7P-di-
chlorodihydro£uorescein ester (Molecular Probes,
Go«ttingen, Germany [24,25]). RHECs were cultured
in 24 well plates coated with gelatine (0.2%, Nun-
clon, Wiesbaden Germany) for 24 h. The culture
medium was removed, the cells were washed three
times with glucose-free modi¢ed Gey’s bu¡er (145
mM NaCl, 5 mM KCl, 1 mM Na2HPO4, 10 mM
HEPES, 1 mM CaCl2, 0.5 mM MgSO4, pH 7.4)
and preincubated with 1 WM H2DCF ester (dissolved
in ethanol) for 45 min. After washing the cells three
times, the cells were incubated with medium contain-
ing glucose (5^30 mM, 15 min). Thereafter, the cells
were observed under the £uorescent microscope (Lei-
ca, DM, IRB, Leitz, Cologne, Germany).
2.10. Statistical analysis
Data were presented as mean þ S.E.M. and were
analysed by the nonparametric Wilcoxon paired
Rank test with Bonferroni correction for multiple
comparisons (Sigmastat). Values with P6 0.05 were
considered to be signi¢cantly di¡erent).
3. Results
Only animals with blood glucose levels higher than
15 mM were classi¢ed as diabetic. In addition, the
chronic hyperglycaemic state was con¢rmed by the
elevated haemoglobin A1 ratios (s 12%) and gluco-
suria which was observed regularly.
3.1. In£uence of diabetes on myocardial NOS activity
In age matched controls, NOS activity amounted
to 133 þ 7 fmol citrulline/min/mg protein and did not
signi¢cantly change during the observation period. In
contrast, the speci¢c activity in hearts of diabetic rats
changed with time and reached activity levels 2.5
times as high as in controls (336 þ 56) after a diabetes
duration of 4 weeks. After a longer duration of dia-
betes the NOS activity slowly declined and was no
longer di¡erent from controls after a diabetes dura-
tion of more than 15 weeks (Fig. 1). A lower NOS
activity than in the controls was only observed after
a very long duration of diabetes (46 weeks, 21 þ 1
fmol/mg/min, n = 6).
An activation or an enhanced expression of one or
all of the three isoforms of NOS could cause the
observed changes in NOS activity. Therefore, the
mRNAs of the NOS isoforms were analysed by
Fig. 1. In£uence of diabetes on myocardial NOS activity. Total
NOS activity was measured in heart homogenates of control
and diabetic rats by the conversion of 3H-L-arginine into citrul-
line as described in Section 2. The speci¢c activity is shown de-
pendent on the duration of diabetes. In age matched controls,
NOS activity did not signi¢cantly change during the observa-
tion period and amounted to 133 þ 7 fmol/mg protein/min.
Data are given as mean þ S.E.M. (n = 5^12). *P6 0.05 versus
control.
Fig. 2. In£uence of diabetes on the levels of mRNA encoding
ecNOS and iNOS. RNA was isolated from hearts of control
and diabetic rats. Using reverse transcription (RT)-PCR, ec-
NOS and iNOS encoding mRNA were ampli¢ed. Two Wg of to-
tal RNA were processed by PCR as described in Section 2. For
each lane, 5 Wl of the PCR were analysed in an 1.5% TAE-aga-
rose gel containing 0.5 Wg ethidium bromide/ml. Original traces
of ecNOS and iNOS in hearts of control and diabetic (4 weeks)
rats to facilitate the recognition of small bands. ec = ecNOS
(387 bp), i = iNOS (279 bp), GA = GAPDH (307 bp), M = stan-
dards.
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PCR as described in Section 2. As shown in Fig. 2,
we detected mRNA encoding ecNOS and iNOs in
heart homogenates of control and diabetic rats, but
we did not detect any amounts of nNOS mRNA. As
compared to controls, in which the amount of ec-
NOS mRNA did not signi¢cantly vary during the
observation time, the amount of mRNA increased
approximately 1.5-fold in diabetes (4 weeks, Fig. 3).
Thereafter a slow decline of ecNOS mRNA was ob-
served similar to activity. After a diabetes duration
longer than 10 and 22 weeks ecNOS mRNA was
slightly reduced as compared to controls (Fig. 3),
however a signi¢cant reduction was only observed
after a diabetes duration of 46 weeks (data not
shown). iNOS mRNA was similarly a¡ected by dia-
betes as ecNOS, but the di¡erences did not reach the
level of signi¢cance (data not shown).
To determine NOS protein, Western blots were
performed using speci¢c antibodies to identify the
isoforms and to quantify the NOS protein. In heart
extracts of control and diabetic rats, ecNOS protein
was detected as a single band with a molecular
weight of 145 kDa. A quantitative evaluation of
the blots showed a large variation in the amount of
ecNOS protein between individual hearts. There was
a small increase in ecNOS protein 6 to 10 weeks after
induction of diabetes which did not, however, reach
the level of signi¢cance (data not shown). We were
not able to detect signi¢cant amounts of iNOS or
nNOS protein in this whole heart preparation.
To get an impression of the cellular distribution of
the isoforms of NOS in the rat heart, we examined
two types of cells in which expression of NOS has
already been shown before, cardiomyocytes [23,26]
and endothelial cells [23,27]. RHEC and cardiomyo-
cytes continuously convert arginine into citrulline,
but the conversion rates were remarkably di¡erent:
endothelial cells converted up to 2235 þ 225 fmol cit-
rulline/min/mg protein (n = 5) arginine into citrulline
and nitric oxide, whereas NOS activity is hardly de-
tected in freshly isolated myocytes which produced
citrulline at a rate less than 1 fmol citrulline/min/mg
protein. Accordingly, most of the nitric oxide re-
leased by the heart should be derived from the endo-
thelium, whereas the cardiomyocytes contribute to
nitric oxide production only to a minor amount. In
agreement with the measured activities, the amount
of steady state mRNA of ecNOS is much higher in
Fig. 3. Quanti¢cation of the in£uence of diabetes on the levels
of mRNA encoding ecNOS. RNA was isolated from hearts of
control and diabetic rats. Using RT-PCR ecNOS encoding
mRNA were ampli¢ed. Two Wg of total RNA were processed
by PCR as described in Section 2. For each lane, 5 Wl of the
PCR were analysed in an 1.5% TAE-agarose gel containing 0.5
Wg ethidium bromide/ml. Diabetes induced changes were quanti-
¢ed by densitometry after normalisation for GAPDH mRNA
of the same sample run in parallel. Further details are given in
Section 2. In controls the amount of ecNOS RNA did not vary
with age (25 weeks) and amounted to 0.61+AU. Data are given
as mean þ S.E.M. (n = 3^10). *P6 0.05 versus control.
Fig. 4. Steady state level of mRNA encoding ecNOS and iNOS
in isolated cardiomyocytes and RHEC. For comparison of the
steady state mRNAs, RNA was isolated from cardiomyocytes
and cultivated RHEC. 0.1 Wg of total RNA were processed by
PCR as described in Section 2. For each lane 5 Wl of the PCR
were analysed in an 1.5% TAE-agarose gel containing 0.5 Wg
ethidium bromide/ml. A part of the RHEC were stimulated by
100 U/ml Q-IFN and 200 U/ml IL-1L for 8 h to induce iNOS.
ec = cNOS product (387 bp), i = iNOS product (279 bp),
n = nNOS product (521 bp), GA = GAPDH product (307 bp).
A typical result of PCR analysis is shown. The experiments
were performed with identical results using three di¡erent endo-
thelial cell lines.
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cultured endothelial cells than in cardiomyocytes
(Fig. 4). iNOS mRNA was only detected in endothe-
lial cells after stimulation of the cells with a mixture
of interleukin (IL)-1L and Q-interferon (Q-IFN) (Fig.
4). nNOS was hardly detected in both types of cells.
The basal levels of mRNA encoding ecNOS were not
signi¢cantly di¡erent in endothelial cells isolated
from control and diabetic rats if cultivated under
identical low glucose (5 mM) conditions for several
passages (s ¢ve passages). A direct comparison of
the amount of ecNOS RNA in endothelial cells
from hearts of control and diabetic rats was, how-
ever, not possible because the yield of cells was too
small to perform appropriate determinations with
primary cells.
3.2. In£uence of high glucose and antioxidants
Since, as previously described for HUVECs [28],
incubation of RHEC with high glucose (22 mM) in-
creased the formation of ROI in RHECs isolated
from control and diabetic rats (H2DCF method,
data not shown), we studied the in£uence of high
glucose, H2O2 and antioxidants on the expression
of ecNOS. Incubation with high glucose (22 mM)
caused a signi¢cant increase in ecNOS mRNA both
in cells from control and diabetic rats (Fig. 5). In-
cubation with D-mannitol or L-glucose (22 mM) did
not mimic the e¡ect of high concentrations of D-glu-
cose. A similar increase in ecNOS-RNA was also
observed after incubation of the cells with H2O2
(100 WM, data not shown). This glucose dependent
increase in ecNOS mRNA could be prevented by
incubation of the cells with the antioxidant K-lipoic
acid (1 Wmol/l).
Since pre-treatment of diabetic rats with K-toco-
pherol prevented an impairment of endothelium de-
pendent vasodilatation as already shown [1], we were
interested whether the in vivo application of an anti-
oxidant is also able to in£uence the activity and the
cardiac expression of NOS. Pre-treatment with high
doses of K-tocopherol caused a signi¢cant reduction
in NOS activity, in both hearts of controls and dia-
betic rats. In controls, NOS activity is reduced by
this treatment to about 5^6% (7 þ 14 fmol/min/mg
protein, n = 5) of the initial activity, whereas in dia-
betes the degree of inhibition is less and the residual
activity amounted to 25% (56 þ 11 fmol/min/mg,
n = 5) of the initial value. However, not only the
activity of NOS was reduced by K-tocopherol treat-
ment, but also the amount of ecNOS protein detect-
able by Western blot. In hearts of diabetic rats
treated with K-tocopherol the amount of ecNOS pro-
tein was diminished to 71 þ 6% (n = 5) of that deter-
mined in healthy controls (100%), whereas in un-
treated diabetic rats ecNOS protein is slightly
increased (10 weeks of diabetes, 115 þ 7% of control,
n = 5). K-Tocopherol did not signi¢cantly a¡ect the
ecNOS mRNA, but further reduced the already low
amount of mRNA encoding iNOS in controls (data
not shown).
4. Discussion
It was the aim of this study to test whether the
attenuated endothelium dependent vasodilator re-
sponsiveness observed in the heart of streptozotocin
diabetic rats is caused by diminished activity and
expression of NOS. Whereas the endothelium depen-
dent dilatation is progressively impaired in diabetes
[1,2], NOS expression and activity are initially in-
creased reaching maximal values after a diabetes du-
Fig. 5. In£uence of high glucose (22 mM) and K-lipoic acid on
the level of mRNA encoding ecNOS in RHEC isolated from
hearts of control and diabetic rats. The relative amounts of the
ecNOS-PCR products are shown resulting from 0.1 Wg total
RNA of RHEC incubated for 32 h either under normoglycae-
mic (5.5 mM, black) or high glycaemic conditions (22 mM,
grey hatched). Lipoic acid (1 WM) inhibited the glucose (22
mM, dark hatched) increased expression of ecNOS. RNA was
isolated, processed and normalised for the GAPDH product as
described in Section 2. Each value is the mean þ S.E.M. from
experiments done in triplicate with two di¡erent cell lines. The
data are given in arbitrary units. *P6 0.05 versus control,
**P6 0.05 untreated versus treated.
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ration of 4^6 weeks. Even after a diabetes duration
of 25 weeks, when the endothelium dependent dila-
tation is already strongly attenuated [1], the activity
of NOS was not yet diminished, but near the control
level. Together with the observation that the im-
paired endothelium dependent relaxation can be pre-
vented by treatment of the diabetic rats with K-toco-
pherol and acutely normalised by the addition of
superoxide dismutase to the perfusion medium
[1,2], our data suggest that the endothelial dysfunc-
tion in hearts of diabetic rats cannot be attributed to
a decreased NOS activity. A signi¢cant loss of NOS
activity was only observed after a diabetes duration
of 46 weeks when the endothelium dependent vaso-
dilatation is completely vanished and the endothe-
lium is severely damaged [1].
In parallel to the changes in activity, the expres-
sion of ecNOS slightly increased after a diabetes du-
ration of 4^6 weeks. There was a slight reduction of
ecNOS mRNA after a diabetes duration of 10 and 22
weeks, but these di¡erences did not reach the level of
signi¢cance. These observations do not support the
hypothesis that the impaired endothelium dependent
relaxation observed in the diabetic rat heart is caused
by changes in ecNOS expression. Interestingly the
changes in ecNOS activity and mRNA were not ac-
companied by counterregulatory alterations in the
expression of iNOS. However, the changes in iNOS
mRNA were very small and did not reach the level of
signi¢cance. Therefore the interpretation of these ob-
servations is limited. Data on the in£uence of diabe-
tes on ecNOS activity and expression are varied
[8,29,30]. In alloxan-diabetic dogs, the reduced coro-
nary production of nitric oxide was associated with a
two-fold increase in aortic iNOS mRNA, but with a
reduction of ecNOS protein [29]. In ventricular my-
ocytes from streptozotocin-diabetic rats, Smith et al.
[30] described a small increase in ecNOS and pro-
vided evidence for the presence of iNOS (Western
blot). In any case, our data exclude that a diminished
expression of NOS is responsible for the impaired
endothelium dependent relaxation observed in dia-
betic rat hearts [1].
Since the NOS activity was determined in heart
extracts and the mRNAs were isolated from the
whole heart, it is not possible to attribute the
changes in activity and expression of NOS to a spe-
ci¢c cellular compartment. There is some evidence
that in addition to endothelium, cardiomyocytes are
able to generate nitric oxide and to express various
types of NOS [26,31]. We assume that the NOS ac-
tivity determined in this study is mainly derived from
cardiac endothelium since the NOS activity and ex-
pression measured in cardiomyocytes isolated from
control and diabetic rat hearts was small as com-
pared to that observed in endothelial cells. The
body of NOS activity and expression is localised in
cardiac endothelium.
Why is the expression of iNOS and ecNOS ele-
vated in hearts of diabetic rats? Our observations
clearly show that there is no di¡erence in the initial
amounts of NOS mRNA (ecNOS and iNOS) in
RHEC isolated from control and diabetic rats if
these cells were cultivated under identical conditions
(5 mM glucose). This observation indicates that the
increase in NOS mRNAs observed in diabetic heart
is a transient consequence of the metabolic defect
caused by the induction of diabetes, but not a stable
and transferable alteration within the endothelial
cells such as it has been shown for Glut-1 [32]. In
line with this assumption we report here an induction
of ecNOS by cultivation of RHEC in high glucose
(22 mM, 32 h). That ecNOS can be induced by high
levels of glucose has already been shown by others
[8,33]. Pieper [8] reported an increase in NOS mRNA
for bovine aortic endothelial cells incubated with
high glucose for 24 h. Long term cultivation of hu-
man aortic endothelial cells (5 days) in high glucose
caused a two-fold increase in ecNOS mRNA as re-
ported by Cosentino et al. [33]. On the other hand, in
human umbilical vein endothelial cells long term in-
cubation with high glucose did not in£uence NOS
(30 mM glucose, 15 days) [34] and Chakravarthy et
al. [35] very recently reported a diminution of ecNOS
expression by high glucose and advanced glycation
end products in retinal microvascular endothelial
cells which was partly prevented by inhibition of
PKC. It is not clear why di¡erent e¡ects of high
glucose have been observed in the various types of
endothelial cells. Di¡erences between macro- and mi-
crovascular origin do not seem to be decisive since
rat heart and retinal endothelial cells are both mainly
microvascular cells [15,35].
Why glucose induces expression of ecNOS has not
yet been elucidated. The promoter region of the hu-
man ecNOS gene contains various regulatory sequen-
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ces for phorbol esters, cAMP, acute-phase proteins,
shear stress and sterol responsive elements [27]. Ex-
ercise and sex hormones are also able to increase
ecNOS mRNA and protein [36^38]. On the other
hand, an increase in ecNOS mRNA could also be
explained by a prolonged half life of the mRNA
species. We cannot decide which of the indicated
mechanisms is responsible for the observed changes.
We did not study the underlying mechanism in detail
for two reasons: ¢rstly the increase in cardiac NOS
mRNA was only temporary and not very impressive.
Secondly the main aim of this study was the question
as to whether the changes in activity and expression
of NOS coincide with the development of endothe-
lium dependent relaxation. Whatever the underlying
mechanism is, our observations that the up-regula-
tion of ecNOS by high glucose can be prevented by
lipoic acid and that H2O2 is also capable of increas-
ing ecNOS mRNA, suggest that reactive oxygen spe-
cies or alterations in the redox state might be in-
volved in induction of ecNOS by glucose. That
high glucose causes the generation of ROI has been
demonstrated in this study for microvascular RHEC,
but similar observations have been reported for other
types of endothelial cells such as porcine aortic and
human umbilical vein endothelial cells [24,25,28,39].
ROI may in£uence the activity and expression of
ecNOS by several mechanisms: a short term hyper-
glycaemia may lead to an activation of ecNOS by
mobilisation of intracellular calcium as suggested
by Graier et al. [39], a long term one may cause an
up-regulation of ecNOS expression as shown in this
study and by Cosentino et al. [33].
Taken together, our data suggest that the impair-
ment of endothelium dependent vasodilatation by the
diabetic heart does not seem to be the consequence
of changes in the activity and expression of NOS.
Rather, endothelial dysfunction in the diabetic rat
heart temporarily coincides with an enhanced NOS
expression and an increased superoxide anion pro-
duction. A similar situation has been described in
hypertension and in atherosclerosis where the im-
paired endothelial dependent vasodilatation has
been suggested to be due neither to decreased NOS
activity nor to a de¢ciency in the availability of L-
arginine, but to an accelerated inactivation of nitric
oxide by ROI [40,41,42]. Our data suggest that a
similar mechanism is working in the diabetic heart
and that the temporary increase in ecNOS is a coun-
terregulatory e¡ect to compensate for the accelerated
degradation of NO by ROI. This interpretation is
supported by the following observations:
b The impaired endothelial dependent responsiveness
is prevented by antioxidants and acutely at least
partially normalised by perfusion of the hearts
with SOD [1].
b The NOS activity and the expression of ecNOS are
temporarily increased in the diabetic heart, but not
diminished in parallel to the development of endo-
thelial dysfunction.
b High glucose is able to enhance the activity of
NOS.
b Diabetes and high glucose are able to upregulate
the expression of ecNOS, a process which is inhib-
ited by lipoic acid suggesting an involvement of
ROI.
b Incubation of RHEC with high glucose leads to a
rapid generation and release of ROI.
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